Maria Norma Villalon Landeros, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · Roots Community Health Center
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
19 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Landeros’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A157942 · Current
Licensed to practise in California · since 2018 · expires 2028-08-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$12,606
Medicare paid this office $12,606 for 91 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 67 | $7,366 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $2,167 | $66 |
| Return visit (30+ min) | 16 | $1,401 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 24 | $524 | $15 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
91 Original Medicare patients in 2024. Average age 72 · Women 67% · Also on Medicaid 36% · Health risk score 1.43. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 58% · Diabetes 45% · Coronary heart disease 24% · Chronic kidney disease 22% · Depression 18% · Cancer 15% · Atrial fibrillation 14% · Heart failure 13%.
The office billed $79,021, Medicare allowed $16,404 and paid $12,606; for 238 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 91 | 238 | 72 | 1.43 | $79,021 | $12,606 |
| 2023 | 54 | 98 | 72 | 1.45 | $37,241 | $5,917 |
| 2022 | 81 | 133 | 70 | 1.45 | $48,643 | $8,294 |
| 2021 | 43 | 90 | 69 | 1.70 | $32,457 | $5,302 |
| 2020 | 19 | 24 | 66 | 1.93 | $11,135 | $1,354 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 36 | $3,090 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $1,565 | $82 |
2022: 2 services
| Short return visit (20+ min) | 53 | $3,638 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $2,285 | $85 |
2021: 2 services
| Short return visit (20+ min) | 18 | $2,073 | $53 |
| Short return visit | 11 | $497 | $38 |
Medicaid work
$109,828 in 2024
Medicaid paid $109,828 for 2,135 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 268 | $103,752 |
| Short return visit (20+ min) | 605 | $5,687 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 143 | $257 |
| Screening for depression is documented as negative, a follow-up plan is not required | 67 | $123 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 96 | $8 |
| BODY MASS INDEX DOCD | 334 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 306 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 316 | $0 |
| 2024 | 2,135 | 8 | 69 | $109,828 |
| 2023 | 6,837 | 21 | 187 | $392,369 |
| 2022 | 9,701 | 21 | 280 | $601,987 |
| 2021 | 4,739 | 18 | 214 | $374,846 |
| 2020 | 32 | 1 | 17 | $11,699 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,065 | $389,470 |
| Short return visit (20+ min) | 1,499 | $795 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 19 | $528 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 38 | $508 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 78 | $387 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 476 | $366 |
| New patient visit (30+ min) | 59 | $114 |
| Alcohol and/or drug screening | 246 | $60 |
| Screening for depression is documented as negative, a follow-up plan is not required | 459 | $60 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 16 | $41 |
| Screening test, pure tone, air only | 41 | $20 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 523 | $12 |
2022
| Clinic visit/encounter, all-inclusive | 1,659 | $599,518 |
| Short return visit (20+ min) | 2,165 | $1,067 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 638 | $341 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 21 | $299 |
| Screening for depression is documented as negative, a follow-up plan is not required | 718 | $265 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 79 | $170 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 20 | $166 |
| Alcohol and/or drug screening | 460 | $96 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 23 | $33 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 178 | $27 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 475 | $4 |
| BODY MASS INDEX DOCD | 950 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,046 | $372,968 |
| Short return visit (20+ min) | 1,187 | $1,490 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 21 | $161 |
| Alcohol and/or drug screening | 183 | $96 |
| Screening for depression is documented as negative, a follow-up plan is not required | 202 | $59 |
| Screening test, pure tone, air only | 58 | $33 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 235 | $18 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 47 | $13 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 208 | $9 |
| BODY MASS INDEX DOCD | 602 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 313 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 20 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 32 | $11,699 |
Drugs they prescribed that Part D paid
$129,764
Pharmacies billed $129,764 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 929) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
776 generic and fewer than 11 brand-name prescriptions · $129,764 in drug cost · 15 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 23 | $28,627 | $1,245 |
| Jardiance | 14 | $23,034 | $1,645 |
| Mounjaro | 12 | $13,951 | $1,163 |
| Atorvastatin | 71 | $559 | $8 |
| Gabapentin | 24 | $498 | $21 |
See all 24 drugs
| Ozempic | 23 | $28,627 | $1,245 |
| Jardiance | 14 | $23,034 | $1,645 |
| Mounjaro | 12 | $13,951 | $1,163 |
| Atorvastatin | 71 | $559 | $8 |
| Gabapentin | 24 | $498 | $21 |
| Albuterol Sulfate Hfa | 12 | $396 | $33 |
| Amlodipine Besylate | 68 | $379 | $6 |
| Metformin | 51 | $341 | $7 |
| Losartan | 55 | $296 | $5 |
| Metoprolol | 24 | $263 | $11 |
| Lisinopril | 28 | $253 | $9 |
| Escitalopram | 16 | $238 | $15 |
| Alendronate | 13 | $233 | $18 |
| Omeprazole | 18 | $231 | $13 |
| Fluticasone Propionate | 17 | $225 | $13 |
| Pantoprazole | 20 | $217 | $11 |
| Famotidine | 14 | $204 | $15 |
| Atenolol | 20 | $167 | $8 |
| Levothyroxine | 16 | $142 | $9 |
| Clopidogrel | 12 | $118 | $10 |
| Sertraline | 16 | $72 | $4 |
| Simvastatin | 11 | $66 | $6 |
| Triamcinolone Acetonide | 11 | $43 | $4 |
| Hydrochlorothiazide | 20 | $28 | $1 |
Year by year
| 2024 | 929 | 126 | 1% (13) | None | $129,764 |
| 2023 | 1,005 | 115 | None | None | $132,042 |
| 2022 | 882 | 137 | None | None | $107,708 |
| 2021 | 481 | 83 | 3% (12) | None | $46,782 |
| 2020 | 348 | 53 | 0% (0) | None | $24,746 |
| 2019 | 273 | 41 | 0% (0) | None | $18,714 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Jardiance | 15 | $25,394 | $1,693 |
| Ozempic | 22 | $22,082 | $1,004 |
| Eliquis | 11 | $7,728 | $703 |
| Atorvastatin | 75 | $1,678 | $22 |
| Amlodipine Besylate | 80 | $1,376 | $17 |
| Tamsulosin | 20 | $928 | $46 |
| Metoprolol | 27 | $918 | $34 |
| Levothyroxine | 49 | $813 | $17 |
| Metformin | 63 | $740 | $12 |
| Losartan | 51 | $722 | $14 |
| Rosuvastatin | 13 | $664 | $51 |
| Gabapentin | 25 | $644 | $26 |
| Lisinopril | 34 | $396 | $12 |
| Pantoprazole | 16 | $367 | $23 |
| Atenolol | 25 | $360 | $14 |
| Alendronate | 14 | $339 | $24 |
| Fluticasone Propionate | 22 | $319 | $15 |
| Famotidine | 16 | $271 | $17 |
| Oxybutynin Chloride | 14 | $253 | $18 |
| Omeprazole | 11 | $218 | $20 |
| Simvastatin | 15 | $159 | $11 |
| Sertraline | 12 | $113 | $9 |
| Hydrochlorothiazide | 23 | $101 | $4 |
2022: 20 drugs
| Ozempic | 14 | $13,096 | $935 |
| Atorvastatin | 68 | $1,313 | $19 |
| Albuterol Sulfate Hfa | 16 | $699 | $44 |
| Losartan | 41 | $654 | $16 |
| Metformin | 55 | $653 | $12 |
| Metoprolol | 21 | $651 | $31 |
| Gabapentin | 21 | $651 | $31 |
| Levothyroxine | 29 | $578 | $20 |
| Amlodipine Besylate | 51 | $576 | $11 |
| Tamsulosin | 20 | $515 | $26 |
| Lisinopril | 33 | $476 | $14 |
| Famotidine | 16 | $256 | $16 |
| Pantoprazole | 11 | $243 | $22 |
| Hydrochlorothiazide | 28 | $215 | $8 |
| Atenolol | 20 | $159 | $8 |
| Simvastatin | 13 | $137 | $11 |
| Fluticasone Propionate | 13 | $121 | $9 |
| Triamcinolone Acetonide | 11 | $106 | $10 |
| Alendronate | 11 | $104 | $9 |
| Metoprolol | 12 | $76 | $6 |
2021: 11 drugs
| Atorvastatin | 33 | $623 | $19 |
| Gabapentin | 19 | $591 | $31 |
| Amlodipine Besylate | 37 | $546 | $15 |
| Losartan | 25 | $511 | $20 |
| Tamsulosin | 11 | $290 | $26 |
| Hydrocodone-Acetaminophen | 11 | $251 | $23 |
| Metformin | 23 | $248 | $11 |
| Lisinopril | 16 | $209 | $13 |
| Glipizide | 12 | $135 | $11 |
| Atenolol | 11 | $108 | $10 |
| Hydrochlorothiazide | 17 | $75 | $4 |
2020: 7 drugs
| Eliquis | 12 | $5,492 | $458 |
| Atorvastatin | 19 | $196 | $10 |
| Fluticasone Propionate | 15 | $131 | $9 |
| Losartan | 13 | $128 | $10 |
| Atenolol | 15 | $110 | $7 |
| Tamsulosin | 14 | $102 | $7 |
| Metformin | 13 | $95 | $7 |
2019: 5 drugs
| Tamsulosin | 15 | $123 | $8 |
| Fluticasone Propionate | 12 | $114 | $10 |
| Atorvastatin | 16 | $103 | $6 |
| Atenolol | 12 | $87 | $7 |
| Ranitidine | 14 | $58 | $4 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2024 | 1 | 1 | None | $122 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $20 | 1 payment
|
See the published payment
| Dexcom | Meals · 2025-10-08 | Dexcom G6 Transmitter | $20 |
See earlier years (2024)
2024: $122
| Regeneron Healthcare Solutions | Dupixent | $122 | 1 payment
|
Professional record
- NPI
- 1477081966
- Licence
- CA A157942California A157942: Current · expires 2028-08-31
- Trained
- Stanford University School of Medicine, 2017
- Group
- Stanford Health Care · Roots Community Health Center
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-05-26
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.